Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Cited by (1,000)

Items 801–900 of 1,000

1. Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformatics methods
   Laner Shi, Xin Chun Shang, Kechao Nie, Zhiqin Lin, Miao Wang, Yinying Huang, Zhang-Zhi Zhu · 2020 · Translational Cancer Research
2. Adaptive ordering and filament polymerization of cell cytoskeleton by tunable nanoarrays
   Jing Dai, Yuan Yao · 2020 · Nano Research
3. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c‑Myc and p53 substrates in patients with dysplastic nevi or melanoma
   Julija Mozūraitienė, Živilė Gudlevičienė, Ieva Vincerževskienė, Aida Laurinavičienė, Justinas Pamedys · 2020 · Oncology Letters
4. Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression
   Despoina Kalfakakou, Daniel C. Cameron, Emily A. Kawaler, Motoyuki Tsuda, Lidong Wang, Xiaohong Jing, Cristina H Hajdu, Dylan L. Tamayo, Yoona Shim, Amanda Ackermann et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
5. Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model
   Isabel A. English, Patrick Joseph Worth, Kevin Hawthorne, Macarena Vergara, Katherine R. Pelz, Ashley L. Kiemen, Vidhi Shah, Katie E. Blise, Carl Pelz, Motoyuki Tsuda et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
6. EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer
   Jianyuan Zeng, Cai Wang, Fiona Ruge, Edison Ke Ji, Tracey Amanda Martin, Andrew James Sanders, Shuqin Jia, Chunyi Hao, Wen G. Jiang · 2024 · Scientific Reports
7. Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer
   Matthew Ebia, Edik Matthew Blais, Y Y Cui, Emanuel F. Petricoin, Michael Jon Pishvaian, Srinivas Gaddam, Jun Gong, Arsen Osipov, Andrew Eugene Hendifar · 2025 · JCO Precision Oncology
8. Targeting RBM10‐Repressed RORB Activity in Liquid Condensates Inhibits Lysosomal Biogenesis and Neuroblastoma Progression via Affecting NF‐κB Signaling
   Yanhua Guo, Xiaojing Wang, Chunhui Yang, Zhijie Wang, Xiaolin Wang, Xinyue Li, Jiaying Qu, Shunchen Zhou, Liduan Zheng, Qiangsong Tong · 2025 · Advanced Science
9. Precision medicine strategy in pancreatic ductal adenocarcinoma
   Anthony Tarabay, Leslie A. Swales, C. Smolenschi, Elie Akoury, Marine Valéry, Alina Cristina Fuerea, Thomas Pudlarz, Valérie Boige, Étienne Rouleau, Maximiliano Gelli et al. · 2025 · ESMO Open
10. Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
    Yamamoto, Noboru, Yan, Dong, Ganju, Vinod, Hou, Xinfang, Pan, Hongming, Shan, Jianzhen, Wang, Liwei, Kim, Sang-We, Richardson, Gary, Sanborn, Rachel E. et al. · 2026 · British Journal of Cancer
11. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation
    Leiling Pan, Medhanie Assmelash Mulaw, Johann Gout, Min Guo, Hina Zarrin, Peggy Schwarz, Bernd Baumann, Thomas Theodor Werner Seufferlein, Martin Wagner, Franz Oswald · 2023 · Cellular and Molecular Gastroenterology and Hepatology
12. Current status and perspectives of genetic testing in gastrointestinal cancer (Review)
    Tasuku Matsuoka, Masakazu Yashiro · 2023 · Oncology Letters
13. Clinicopathological and molecular characterization of KRAS wild‐type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes
    Kazuhiro Toriyama, Katsuhiro Masago, Noriko Shibata, Masataka Haneda, Takamichi Kuwahara, Seiji Natsume, Shota Kobayashi, Yasuko Fujita, Eiichi Sasaki, Kenji Yamao et al. · 2025 · The Journal of Pathology
14. Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition
    Tzu‐Lei Kuo, Ya‐Chin Hou, Yan‐Shen Shan, Li‐Tzong Chen, Wen‐Chun Hung · 2025 · Clinical and Translational Medicine
15. Immunologic specificity in glioblastoma: Antigen discovery and translational implications
    Cameron M. Hill, Anthony Z. Wang, Brian Hsueh, Ramiro Ramirez, Ngima D. Sherpa, Marcelo Azevedo Costa, Ofir Williams, Li Mao, Gavin P. Dunn · 2025 · Neuro-Oncology Advances
16. Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy
    Ida Micaily, Edik Matthew Blais, Randi Zukas Carhart, Sophia Lam, Steven J. Cohen, Shawna J. Cannaday, David Charles Halverson, Lynn McCormick Matrisian, Patricia DeArbeloa, Dzung Thach et al. · 2023 · JCO Precision Oncology
17. Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma
    Aziz Zaanan, Victoire Dabout, Simon Garinet, D. Giraud, Géraldine Perkins, Julien Taı̈eb, Claire Gallois · 2024 · ESMO Open
18. Advancing targeted therapies in pancreatic cancer: Leveraging molecular abberrations for therapeutic success
    Tanvi Gupta, Mohd Murtaza · 2025 · Progress in Biophysics and Molecular Biology
19. Cholestyramine as a promising, strong anion exchange resin for direct capture of genetic biomarkers from raw pancreatic fluids
    Andrew J. Hilmer, R. Brooke Jeffrey, Walter G. Park, Chaitan Khosla · 2016 · Biotechnology and Bioengineering
20. Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia
    Amy L. Body, Rachel Wong, Jeremy David Shapiro, Azim Jalali, Sue‐Anne McLachlan, Sumitra S. Ananda, Lara Rachel Lipton, Prasad D. Cooray, Peter Gibbs, Belinda Lee et al. · 2020 · Internal Medicine Journal
21. KRAS mutation analysis by droplet digital PCR of duodenal juice from patients with MODY8 and other pancreatic diseases
    Man Hung Choi, Erling Tjora, Rakel Brendsdal Forthun, Trond Engjom, Helge Ræder, Randi Hovland, Anders Molven · 2021 · Pancreatology
22. Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma
    Leonie Wheeldon, Mary Jones, Ben Probyn, Dushyant Shetty, James Garvican · 2022 · Journal of Molecular Pathology
23. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
    А. А. Качмазов, Л. В. Болотина, Anna L. Kornietskaya, Olesya A. Kuznetsova, Maxim A. Ivanov, А. А. Феденко · 2022 · Frontiers in Oncology
24. A Subset of Pancreatoblastomas May Arise From an Adenomatous Precursor
    Jonathan C. Slack, Marie‐Anne Bründler, Adrian Harold Box, Konstantin Koro · 2022 · Pancreas
25. LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma
    Jingyun Liu, Mengyue Wang, Miaowen Wang, Fu Wang, Beilei Zhang · 2023 · Biochemical Genetics
26. Epigenetic therapeutic strategies in pancreatic cancer
    Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda · 2024 · International review of cytology
27. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
    Timothy Chao, Zixuan Wang, Wilbur Bo Bowne, Clifford J. Yudkoff, Ava Torjani, Vishal Swaminathan, Taylor R. Kavanagh, Austin Roadarmel, Cyrus J. Sholevar, Shawnna Cannaday et al. · 2024 · Archives of Pathology & Laboratory Medicine
28. Copy number aberrations from Affymetrix SNP 6.0 genotyping data—how accurate are commonly used prediction approaches?
    Adriana Pitea, Ivan Kondofersky, Steffen Sass, Fabian Joachim Theis, Nikola S. Mueller, Kristian Unger · 2018 · Briefings in Bioinformatics
29. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
    Eva Segelov, Florian Lordick, David Goldstein, Lorraine A. Chantrill, Daniel Gerald Croagh, Ben J. Lawrence, Dirk Arnold, Ian Chau, Radka Lordick Obermannova, Timothy Jay Price · 2017 · Expert Review of Anticancer Therapy
30. Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach
    Antonio Pea, Liang Cheng C, Claudio Luchini · 2019 · Expert Review of Precision Medicine and Drug Development
31. Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
    Joyce K. Thompson, Filip Bednar · 2021 · Epigenomes
32. Molecular mutation characteristics of mismatch and homologous recombination repair genes in gastrointestinal cancer
    Xingcun Liu, Haiping Yang, Xiaohong Wu, Kai Huang, Paul Ma, Pengpeng Jiang, Weiqing Zheng, Tom Tang, Dujuan Liu · 2019 · Oncology Letters
33. Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stroma
    Jing He, H. Carlo Maurer, Sam R. Holmstrom, Tao Su, Aqeel Ahmed, Hanina H. Hibshoosh, John A. Chabot, Paul E. Oberstein, Antonia R. Sepulveda, Jeanine M. Genkinger et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
34. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma
    Akimasa Hayashi, Jun Fan, Ruoyao Chen, Yu-jui Ho, Alvin P. Makohon-Moore, Yi Zhong, Jungeui Hong, Hitomi Sakamoto, Marc A. Attiyeh, Zachary A. Kohutek et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
35. WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway
    Genso Notoya, Takahiro Kishikawa, Kengo Yasugi, Takuma Iwata, Takahiro Seimiya, Koji Miyabayashi, Ryota Takahashi, Keisuke Yamamoto, Hideaki Ijichi, Motoyuki Otsuka et al. · 2024 · Journal of Gastroenterology
36. The PIN1–p38–CtIP signalling axis protects stalled replication forks from deleterious degradation
    Francesca Vivalda, Marco Gatti, Letizia Manfredi, Hülya Dogan, Antônio Porro, Giulio Collotta, Ilaria Ceppi, Christine von Aesch, Vanessa van Ackeren, Sebastian Wild et al. · 2025 · Nucleic Acids Research
37. Recent Advancements in the Relationship Between the Autonomic Nervous System and the Pancreas, Encompassing the Regulation of Regeneration and Apoptosis
    T. Kiba · 2025 · Cells
38. The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
    Akimasa Hayashi, Yu-Jui Ho, Alvin P. Makohon-Moore, Amanda Zucker, Jungeui Hong, Shigeaki Umeda, Elias-Ramzey R. Karnoub, Jinlong Huang, Priscilla Baez, Rajya L. Kappagantula et al. · 2025 · Cancer Research Communications
39. The Role of Tumor-Intrinsic HuR in Modeling the Pancreatic Tumor Microenvironment: Molecular Mechanisms and Therapeutic Opportunities
    Katherine R. Pelz, Kyle P. Gribbin, Tess Sevetson, Jonathan Robert Brody · 2025 · Molecular and Cellular Biology
40. Cancer Prevention/Interception Agent Development
    Mark Steven Miller, Frank G. Ondrey · 2025 · Cancer Prevention Research
41. Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells
    Maj-Britt Paulsohn, Klara Henrike Frahnert, Denise Schlösser, Joana Oschwald, Waltraut Kopp, Xin Fang, Carolin Schneider, Constanza Tapia Contreras, Adi Danieli‐Mackay, Fabian Ludewig et al. · 2025 · Cell Death and Disease
42. Lung-only metastatic pancreatic cancer: Differences in patients ‘characteristics, molecular profile and survival
    Alice Boilève, Léa Mercier, Baptiste Bonnet, Anthony Tarabay, Sarah Blanchet-Deverly, Antoine Hollebecque, Cristina Smolenschi, Marine Valéry, Matthieu Delaye, Thomas Pudlarz et al. · 2026 · European Journal of Cancer
43. Epigenetic dysregulation and microenvironment remodeling in pancreatic cancer
    Ningning Niu, Mo Chen, Jing Xue · 2026 · Trends in cancer
44. The utility of molecular studies on pancreatic cystic lesions: A comprehensive review
    Rong Xia, Xiaoying Liu, Cristina H Hajdu, Wenqing Cao, James N. Kaz, Tamas A. Gonda, Aylin Simsir · 2024 · Human Pathology Reports
45. CancerHubs: a systematic data mining and elaboration approach for identifying novel cancer-related protein interaction hubs
    Ivan Ferrari, Federica De Grossi, Giancarlo Lai, Stefania Oliveto, Giorgia Deroma, Stefano Biffo, Nicola Manfrini · 2024 · Briefings in Bioinformatics
46. Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study
    Saskia Hussung, Maria E. Hess, Elham Bavafaye Haghighi, Uwe A. Wittel, Melanie Boerries, Ralph Fritsch · 2024 · Diagnostics
47. Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
    Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, Yoshito Itoh · 2025 · Japanese Journal of Clinical Oncology
48. Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression
    Pit Preckwinkel, Khursheed Ul Islam Mir, Florian W. Otto, Hend Elrewany, Andrea Sinz, Stefan Hüttelmaier, Nadine Bley, Tony Gutschner · 2025 · Cancers
49. A novel KRAS exon 2 drop-off digital PCR assay for mutation detection in cell-free DNA of cancer patients
    Bianca Addamo-De Nard, Meret Geissmann, Dilara Akhoundova, C. Pistoni, T. Brezina, M. Zoche, Achim Weber, S. Hussung, Ralph Fritsch · 2025 · Diagnostic Pathology
50. Erianin inhibits the proliferation and stemness of pancreatic cancer cells by interacting with MEK1/2
    Yiqi Zhu, Sheng Zhou, Fu-Qin Yang, Haishan Zhang, Jiaxin Luo, Fei Xie, Dongdong Liu, Yuhe Lei, Lijuan Deng · 2025 · Biochemical Pharmacology
51. Genetic and oncogenic features of RASGRF fusions
    Sreya Das, Daniel S. Lenchner, Ellen Jaeger, Lisa W. Hunihan, Dana F. DeSantis, Stamatina Fragkogianni, Karyn Ronski, Frederick Hugh Wilson · 2025 · npj Precision Oncology
52. Organoids in the research of pancreatic neoplasms: cultivation, applications, and limitations
    Changwei Du, Yueze Liu, Xiaoyue Lu, Menggang Zhang, Shijuan Jiang, Zhe Cao, Gang Yang, Jiangdong Qiu, Taiping Zhang, Yupei Zhao · 2025 · Cancer Letters
53. The Role of TGF-β in Gastrointestinal Cancers
    Hong Wang, Xiang Gong, Jingyu Xu, Rui Xie · 2018 · Journal of Cancer Science & Therapy
54. BATCAVE: calling somatic mutations with a tumor- and site-specific prior
    B. Mannakee, Ryan N. Gutenkunst · 2019 · bioRxiv
55. Resection of multiple invasive pancreatic ductal adenocarcinomas: A diagnostic dilemma distinguishing multicentric carcinogenesis from intrapancreatic metastasis
    Nobuyuki Ohike, Tomoko Norose, Yuichi Takano, Fumitaka Niiya, Masatsugu Nagahama, Kenichi Matsuo, Kuniya Tanaka, Toru Furukawa · 2020 · Pathology International
56. The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer
    Zachary Heinzman, Connor Schmidt, Marek K. Sliwinski, Nalin C. W. Goonesekere · 2021 · Pharmaceuticals
57. The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
    Ricki T. Krog, Noel F.C.C. de Miranda, Alexander L. Vahrmeijer, Nigel G. Kooreman · 2021 · Cancers
58. Repeat expression is linked to patient survival and exhibits single nucleotide variation in pancreatic cancer revealing LTR70:r.879A>G
    Cihangir Yandım, Gökhan Karakülah · 2022 · Gene
59. Regulatory role of RNA modifications in the treatment of pancreatic ductal adenocarcinoma (PDAC)
    Hao Chen, Wenhao Luo, Xiaoyue Lu, Taiping Zhang · 2023 · Heliyon
60. PSCA is a critical biomarker for predicting the prognosis of KRAS/TP53 mutant pancreatic cancer patients
    Mengyuan Gong, Bo Zhang, Xueni Wang, Zeen Zhu, Wei Li, Liang Han, Zheng Wu, Qingyong Ma, Zheng Wang, Weikun Qian · 2023 · Journal of Pancreatology
61. Infection with COVID-19 promotes the progression of pancreatic cancer through the PI3K-AKT signaling pathway
    Xusheng Zhang, Bendong Chen, Kejun Liu, Yongxin Ma, Yimin Liu, Hongcai Zhou, Peng Wei · 2023 · Discover Oncology
62. Single-cell transcriptome reveals the heterogeneity of malignant ductal cells and the prognostic value of REG4 and SPINK1 in primary pancreatic ductal adenocarcinoma
    Yutian Ji, Qianhui Xu, Weilin Wang · 2024 · PeerJ
63. Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas
    Marie-Lucie Racu, Andréa Alex Schiavo, Claude Van Campenhout, Nancy De Nève, Thomas Masuy, Calliope Maris, Christine Decaestecker, Myriam Remmelink, Isabelle J. Salmon, Nicky D’Haene · 2024 · Experimental and Molecular Pathology
64. Temperature-Controlled pNIB/PTX Micelles for Improved Paclitaxel Delivery in Ovarian Cancer Treatment
    Ji-Hye Kang, Young-Jae Cho, Ji‐Young Hwang, Sang-Yu Park, Jung-Joo Choi, E Sun Paik, Han‐Sem Kim, Jeong‐Won Lee, Ueon Sang Shin · 2025 · ACS Biomaterials Science & Engineering
65. Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT database
    Go Endo, Kazunaga Ishigaki, Yousuke Nakai, Hiroto Nishio, Koshiro Fukuda, Kota Ishida, Shinya Takaoka, Yurie Tokito, Rintaro Fukuda, Kensaku Noguchi et al. · 2025 · Journal of Gastroenterology
66. Validation of Isoform- and Mutation-Specific RAS Antibodies
    Andrew M. Waters, Channing J. Der · 2021 · Methods in molecular biology
67. Analysis of Axin2 expression and function in murine models for pancreatic cancer
    Dietmar Zechner, Tim Kroemer, Ann-Christin Albert, Maria Schönrogge, Tobias Radecke, Brigitte Vollmar · 2016 · Cell & Bioscience
68. A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease
    John M Stahl, Zenta Walther, Bryan William Chang, Howard S. Höchster, Kimberly L. Johung · 2017 · Cureus
69. La caractérisation moléculaire définit plusieurs sous-types d’adénocarcinome canalaire du pancréas
    Jérôme Raffenne, Jerome F. Cros · 2017 · Bulletin du Cancer
70. Braking the cell’s cycle and invigorating T-cell immunity against pancreatic cancer
    Gregory B. Lesinski · 2020 · Gut
71. Targeting dynamics of subclones of GI, liver and pancreatic cancers
    Dimosthenis E. Ziogas, Georgios K. Glantzounis, Theodore Liakakos, Dimitrios H Roukos · 2016 · Expert Review of Gastroenterology & Hepatology
72. Targeted Therapies for Pancreatic Cancer
    Vincent Bernard, Anirban Maitra · 2018 · Wiley eBooks
73. Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses
    Sebastian Mueller, Sebastian Lange, Katharina A. N. Collins, Stefan Krebs, Helmut Blum, Günter Schneider, Lena Rad, Dieter Saur, Roland Rad · 2020 · Nature Communications
74. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma
    Akimasa Hayashi, Yu-Jui Ho, Alvin P. Makohon-Moore, Amanda Zucker, Jungeui Hong, Johannes G. Reiter, Jinlong Huang, Lance Zhang, Marc A. Attiyeh, Priscilla Baez et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
75. Anticancer Effects of Fucoxanthin in a PDX Model of Advanced Stage Pancreatic Cancer with Alteration of Several Multifunctional Molecules
    Masaru Terasaki, Sally Suzuki, Takuji Tanaka, H. Maeda, Masaki Shibata, Kazuo Miyashita, Yasuhiro Kuramitsu, Junichi Hamada, Tohru Ohta, Shigehiro Yagishita et al. · 2023 · Onco
76. Emerging Systemic Therapy Considerations for Pancreatic Cancer
    Kai-li Liang, Matthew Z. Guo, Neeha Zaidi · 2025 · Seminars in Radiation Oncology
77. Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer
    Olatunji Boladale Alese, Robert Donald Harvey, Christina Wu, Elise Hitron, Hannah Collins, Suzanne Scott, Conor Ernst Steuer, Mehmet Asım Bilen, Bradley Curtis Carthon, Jeffrey M. Switchenko et al. · 2025 · The Oncologist
78. LY6D identifies persistent stem-like cells driving pancreatic tumourigenesis
    Juanjuan Shi, Xian Wang, Yingying Tang, Shixin Meng, Zhengyan Zhang, Ping Lu, Junyi Xu, Feier Yu, X. Wang, Zheng Wang et al. · 2026 · Gut
79. CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance
    Alex Watterson, Gabriele Picco, Vivien Veninga, Youhani Samarakoon, Chiara Maria Cattaneo, Sara F. Vieira, Emre Karakoç, Shriram G. Bhosle, Thomas Battaglia, Sarah Consonni et al. · 2026 · Cell Reports Medicine
80. Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas
    Antonio Pea, Xiaotong T. He, Rosie Upstill-Goddard, Claudio Luchini, Leonor Patricia Schubert Santana, Stephan B. Dreyer, Fraser Duthie, Nigel Balfour Jamieson, Colin J. McKay, Euan J. Dickson et al. · 2026 · Nature Communications
81. Resection for pancreatic cancer metastases contributes to survival
    Hiroki Sato, Junpei Sasajima, Tetsuhiro Okada, Akihiro Hayashi, Hidemasa Kawabata, Takuma Goto, Kazuya Koizumi, Nobue Tamamura, Hiroki Tanabe, Mikihiro Fujiya et al. · 2020 · Medicine
82. Docosahexaenoic Acid Inhibits Cell Proliferation through a Suppression of c-Myc Protein in Pancreatic Ductal Adenocarcinoma Cells
    Jia‐Ning Syu, Der‐Yen Lee, Hung‐Chang Hung, Chia-Ying Li, Hung‐Yu Lin, En‐Pei Isabel Chiang, Yiheng Chen, Shu‐Ming Huang, Feng‐Yao Tang · 2021 · Antioxidants
83. A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer
    Zhihang Xu, Wenquan Wang, Liang Liu, Wenhui Lou · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
84. Clinical Updates for Gastrointestinal Malignancies
    Carmelo Laface, Riccardo Memeo · 2023 · Journal of Personalized Medicine
85. Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses
    Sahana Jayaraman, Janelle Marie Montagne, Thomas R. Nirschl, Emily F. Davis-Marcisak, Jeanette Johnson, Amanda L. Huff, Meng-Hsuan Hsiao, Julie M. Nauroth, Thatcher Ross Heumann, Jelani C. Zarif et al. · 2023 · Cell Reports Methods
86. Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma
    Biao Dong, Yueshan Zhang, Han Gao, Jia Liu, Jiankun Li · 2024 · Biochemical Genetics
87. Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
    Hannah E. Trembath, Jen Jen Yeh, Nicole Lopez · 2024 · Cancer treatment and research
88. Rac1 GTPase Regulates the βTrCP-Mediated Proteolysis of YAP Independently of the LATS1/2 Kinases
    Chitra Palanivel, Tabbatha N. Somers, Bailey M. Gabler, Yuanhong Chen, Yongji Zeng, Jesse L. Cox, Parthasarathy Seshacharyulu, Jixin Dong, Ying Yan, Surinder K. Batra et al. · 2024 · Cancers
89. Blood mir-331-3p is a potential diagnostic marker for giant panda (Ailuropoda melanoleuca) testicular tumor
    Yan Zhu, Zhi Huang, Caiwu Li, Chengyao Li, Ming Wei, Linhua Deng, Wenwen Deng, Xiao Zhou, Kai Wu, Bo Yang et al. · 2024 · BMC Veterinary Research
90. Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
    Vasiliki Liaki, Blanca Rosas-Pérez, Carmen E. Guerra · 2025 · Cancers
91. Molecular interplay of ARID1A in gastrointestinal cancers
    Alina Athar, Ejaj Ahmad, Pinki Bera, Md Abu Nasar, Khalid Imtiyaz, Mohammad Moshahid Alam Rizvi, Sundeep Singh Saluja · 2025 · Medical Oncology
92. The E3 ubiquitin ligase ZNRF3 restricts WNT receptor complex activity by stimulating the selective degradation of WNT-engaged FZD
    Bo Lu, Feng Cong · 2025 · Science Signaling
93. Precision Therapy of Pancreatic Cancer: From Bench to Bedside
    Katrin J. Ciecielski, Alexandra Berninger, Hana Algül · 2020 · Visceral Medicine
94. KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas
    Meghan L. Rudd, Nancy Fisher Hansen, Xiaolu Zhang, Mary Ellen Urick, Suiyuan Zhang, Maria J. Merino, James C. Mullikin, Lawrence C. Brody, Daphne W. Bell · 2022 · PLoS ONE
95. Metastasierung von Pankreastumoren
    Lena Häberle, Rickmer Braren, Anna Melissa Schlitter, Iréne Esposito · 2015 · Der Pathologe
96. Emerging Therapeutic Targets in Pancreatic Adenocarcinoma
    Jennifer Hsing Choe, James L. Abbruzzese · 2016 · Springer eBooks
97. Precision Medicine Based on Next-Generation Sequencing and Master Controllers
    Katerina Dukleska, Charles J. Yeo, Michael Jon Pishvaian, Jonathan Robert Brody · 2018 · Springer eBooks
98. Review of the Ubiquitin Role in DNA Repair and Tumorigenesis, with Emphasis in Breast Cancer Treatment; Current Data and Future Options
    Despoina Mourtzoukou, Ioannis G. Drikos, Nikolaos D. Goutas, Dimitris Vlachodimitropoulos · 2018 · InTech eBooks
99. Phytochemical based sestrin2 pharmacological modulators in the treatment of adenocarcinomas
    A. Alausa, U. C. Victor, Ugwu Obiora Celestine, Ismail Abiodun Eweje, T. Balogun, Rofiat Adeyemi, M. Olatinwo, A. Ogunlana, O. Oladipo, Barakat Olaleke · 2021 · Phytomedicine Plus
100. Therapeutic Cancer Vaccines
     Christopher Ryan Heery, Anteneh A. Tesfaye, Benjamin Weinberg, John Lindsay Marshall · 2017 · Springer eBooks